2,197,803 Shares Galmed Pharmaceuticals Ltd. Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • February 18th, 2021 • Galmed Pharmaceuticals Ltd. • Pharmaceutical preparations • New York
Galmed Pharmaceuticals Ltd., a corporation organized under the laws of the State of Israel (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) for whom you are acting as representative (the “Representative”), an aggregate of 2,197,803 ordinary shares of the Company, par value NIS 0.01 per share (the “Ordinary Shares”). The 2,197,803 Ordinary Shares to be sold by the Company are called the “Firm Shares”. In addition, the Company has granted to the Underwriters an option to purchase up to an additional 329,670 Ordinary Shares (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares”.
